Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Mar 15, 2022; 14(3): 664-677
Published online Mar 15, 2022. doi: 10.4251/wjgo.v14.i3.664
Published online Mar 15, 2022. doi: 10.4251/wjgo.v14.i3.664
Figure 2 N-nitroso compound treatment induces gastric epithelial cell malignant transformation.
A: Cell proliferation monitored by cell counting in N-methyl-N’-nitro-N-nitrosoguanidine (MNNG)/N-methyl-N-nitroso-urea (MNU)-treated and control cells; B and C: Cell anchorage-independent growth on soft agar and cell colony formation. Top, representative images; bottom, quantitative results of cell colony per field; D: Wound healing assay. Top, representative images of wound healing assay; right, relative percentage of wound closure after treatment; E and F: Tumor growth curve and tumor weight in nude mice injected subcutaneously with the transformed cells induced by MNNG/MNU and control cells. The analyses were repeated three times, and the results are expressed as the mean ± SD. aP < 0.05; bP < 0.01.
- Citation: Chen YX, He LL, Xiang XP, Shen J, Qi HY. O6-methylguanine DNA methyltransferase is upregulated in malignant transformation of gastric epithelial cells via its gene promoter DNA hypomethylation. World J Gastrointest Oncol 2022; 14(3): 664-677
- URL: https://www.wjgnet.com/1948-5204/full/v14/i3/664.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i3.664